Cargando…
The TRIPS Agreement implementation in Brazil : patents in the pharmaceutical area /
Brazil's insertion into the World Trade Organization (WTO) has stimulated economic growth, as the country has been benefiting from lower trade barriers. The country has accepted the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) - Annex 1C of the WTO agreement - whic...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Baden-Baden, Germany : Augsburg :
Nomos ; MIPLC, Munich Intellectual Property Law Center,
2015.
|
| Edición: | 1. edition. |
| Colección: | MIPLC studies ;
v. 25. |
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Cover; I. CHAPTER. INTRODUCTION; II. CHAPTER. THE FRAMEWORK OF TRIPS; III. CHAPTER. THE BRAZILIAN PATENT SYSTEM; IV. CHAPTER. ANALYZING THE BRAZIL CASE; V. CHAPTER. CONCLUDING REMARKS; ANNEX: Law 9279, of May 14, 1996; Bibliography; A. Brazilian context prior to TRIPS; B. TRIPS Agreement; C. Remarks on the Applicability of TRIPS in Brazil; A. Overview; B. Patents on Pharmaceuticals; C. Provisions on Compulsory License; A. General Overview: Brazilian statistics and the public healthcare system; B. AIDS in Brazil; C. The Cases of Kaletra and Efavirenz
- D. Impacts of the WTO Free Trading System on BrazilI. Books, Articles, Manuscripts and Other Documents; II. International Treaties / National Legislation; III. Cases; 1. General Principles; 2. TRIPS Provisions on Patent Law; 3. The Pharmaceutical Industry Context; 1. The Constitutional Clause; 2. General Provisions on Patentability; 3. Term of Protection and Rights Conferred by Patents; 1. The Prior Consent Requirement; 2. Second Medical Use Inventions; 1. Previous Law; 2. Provisions of Law 9279/1996; 1) Statistics; 2) The Anti-AIDS Program
- 1. The Panel Against the US for Cotton Subsidies2. Remarks on the Overall Pharmaceutical Scenario; 2.1. Patentable Subject Matter and Conditions on Patent Applicants; 2.2. Rights Conferred and Term of Protection; 2.3. Flexibilities within TRIPS concerning Patents; 2.4. Other Provisions; 3.1. The Doha Declaration on the TRIPS Agreement and Public Health; 3.2. The Decision Implementing Paragraph 6 of the Doha Declaration; 1.1) Introduction of Article 229-C in the Patent Statute and Competence of the ANVISA
- 2.1) INPI Examination Guidelines, ANVISA Policies and Debates on New Examination Guidelines2.2) Discussions in Congress and Court Decisions; 2.3) Further Remarks; 2.1) Abuse of Economic Power and Lack of Local Exploitation; 2.2) Dependent Patents; 2.3) Procedural Aspects; 2.4) Cases of National Emergency or Public Interest; 1.1. Cross-retaliation on IP rights; 1.2. Ongoing Discussions; 2.3.1. Rules on Implementation and Protection of Existing Subject Matter; 2.3.2. Exclusions from Patentable Subject Matter; 2.3.3. Exhaustion and Parallel Importation
- 2.3.4. General Exception Rules2.3.5. Compulsory Licenses; 2.1.1) Abusive Exercise of Rights or Abuse of Economic Power; 2.1.2) Insufficient or Non-Exploitation in Brazilian Territory; 2.1.3) Economic Capacity of the Licensee and the Importation Exception; 2.1.2.1) Analysis under TRIPS; 2.1.2.2) The Panel filed by the USA before the WTO